NASDAQ
Pathfinder Cell Therapy, Inc. (PFND) has a free cash flow growth of -81.63% as of Friday, May 29, 2026. This represents a 512.15% decrease compared to its 12-month average of 19.81%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.